•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

L&L, ELP act on UK’s Inflexion PE buy of medical science database service Pharmaspectra

UK-based Inflexion Private Equity (“Inflexion”), a mid-market private equity fund with a portfolio of more than 70 operating companies around the world, has bought Pharmaspectra LLC, which provides scientific knowledge services for the medical and pharmaceutical industry.

Inflexion is pleased to announce that it has agreed to acquire Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion’s dedicated lower mid‐market fund.

Inflexion Press Release

L&L Partners advised Inflexion Private Equity led by a team of partner Damini Bhalla, who was assisted by managing associate Akshay Jain, and associates Arsh Khan, Kanchan Modak and Udyan Arya Shrivastava.

Update 25 March 2020: Economic Laws Practice (ELP) advised Pharmaspectra LLC led by a team including partner Amit Manubarwala, associate partner Ananthram Ganesh and associate manager Alysha Razvi.


Deal value: Confidential

Primary jurisdiction of deal: UK

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

No comments yet: share your views